×

img Acces sibility Controls

Research Projects Banner

Research Projects

Cancer Immunotherapy:Mechanism-Based design of Potent Inhibitor for Indoleamine 2,3-dioxygenase-1

Funding Organization
Funding Organization
Department of Science and Technology (DST)
Science and Engineering Research Board (SERB), New Delhi
Quick Information
Area of Research
Chemical Sciences
Focus Area
Cancer Immunotherapy
Start Year
2016
Sanction Amount
₹ 50.82 L
Status
Ongoing
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
N/A
Startup (If Any)
00
No. of Patents
Filed :00
Grant :00
arrowtop